DE60027928D1 - MENSCHLICHES, GEBäRMUTTERKREBS-SPEZIFISCHES SUPPRESSORPROTEIN, FüR DAS PROTEIN KODIERES POLYNUKLEOTID, MIT DEM POLYNUKLEOTID TRANSFORMIERTE ZELLE UND VERFAHREN ZUR UNTERDRüCKUNG DER PROLIFERATION VON KREBSZELLEN UNTER VERWENDUNG DES EXPRESSIONSVEKTORS - Google Patents

MENSCHLICHES, GEBäRMUTTERKREBS-SPEZIFISCHES SUPPRESSORPROTEIN, FüR DAS PROTEIN KODIERES POLYNUKLEOTID, MIT DEM POLYNUKLEOTID TRANSFORMIERTE ZELLE UND VERFAHREN ZUR UNTERDRüCKUNG DER PROLIFERATION VON KREBSZELLEN UNTER VERWENDUNG DES EXPRESSIONSVEKTORS

Info

Publication number: DE60027928D1
Authority: DE; Germany
Prior art keywords: polynucleotide; expression vector; cancer; proliferation; protein
Prior art date: 2000-04-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE60027928T

Other languages

English (en)

Other versions

DE60027928T2 (de

Inventor

Jin Woo Kim

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-25

Filing date

2000-12-04

Publication date

2006-06-14

2000-12-04 Application filed by Individual filed Critical Individual

2006-06-14 Application granted granted Critical

2006-06-14 Publication of DE60027928D1 publication Critical patent/DE60027928D1/de

2007-01-04 Publication of DE60027928T2 publication Critical patent/DE60027928T2/de

2020-12-05 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

206010028980 Neoplasm Diseases 0.000 title abstract 5
201000011510 cancer Diseases 0.000 title abstract 5
102000040430 polynucleotide Human genes 0.000 title abstract 5
108091033319 polynucleotide Proteins 0.000 title abstract 5
239000002157 polynucleotide Substances 0.000 title abstract 5
239000013604 expression vector Substances 0.000 title abstract 4
230000035755 proliferation Effects 0.000 title abstract 2
102000004169 proteins and genes Human genes 0.000 title 2
108090000623 proteins and genes Proteins 0.000 title 2
102000001742 Tumor Suppressor Proteins Human genes 0.000 abstract 2
108010040002 Tumor Suppressor Proteins Proteins 0.000 abstract 2
210000004027 cell Anatomy 0.000 abstract 2
239000000225 tumor suppressor protein Substances 0.000 abstract 2
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 abstract 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
210000004102 animal cell Anatomy 0.000 abstract 1
230000006907 apoptotic process Effects 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
244000005700 microbiome Species 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Zoology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Public Health (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

DE60027928T 2000-04-25 2000-12-04 MENSCHLICHES, ZERVIKALKREBS-SPEZIFISCHES SUPPRESSORPROTEIN, FüR DAS PROTEIN CODIERENDES POLYNUKLEOTID, MIT DEM POLYNUKLEOTID TRANSFORMIERTE ZELLE UND VERFAHREN ZUR UNTERDRÜCKUNG DER PROLIFERATION VON KREBSZELLEN UNTER VERWENDUNG DES EXPRESSIONSVEKTORS Expired - Fee Related DE60027928T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
KR10-2000-0021897A KR100426455B1 (ko)	2000-04-25	2000-04-25	인간 암 억제 유전자, 이에 의해 코딩되는 단백질, 이를포함하는 발현 벡터 및 이 벡터로 형질전환된 세포
KR2000021897		2000-04-25
PCT/KR2000/001406 WO2001081387A1 (en)	2000-04-25	2000-12-04	Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferation of cancer cell using the expression vector

Publications (2)

Publication Number	Publication Date
DE60027928D1 true DE60027928D1 (de)	2006-06-14
DE60027928T2 DE60027928T2 (de)	2007-01-04

Family

ID=36251014

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60027928T Expired - Fee Related DE60027928T2 (de)	2000-04-25	2000-12-04	MENSCHLICHES, ZERVIKALKREBS-SPEZIFISCHES SUPPRESSORPROTEIN, FüR DAS PROTEIN CODIERENDES POLYNUKLEOTID, MIT DEM POLYNUKLEOTID TRANSFORMIERTE ZELLE UND VERFAHREN ZUR UNTERDRÜCKUNG DER PROLIFERATION VON KREBSZELLEN UNTER VERWENDUNG DES EXPRESSIONSVEKTORS

Country Status (11)

Country	Link
US (1)	US6977296B2 (de)
EP (1)	EP1282641B1 (de)
JP (1)	JP3749182B2 (de)
KR (1)	KR100426455B1 (de)
CN (1)	CN1216909C (de)
AT (1)	ATE325812T1 (de)
AU (1)	AU2001220255A1 (de)
CA (1)	CA2405983A1 (de)
DE (1)	DE60027928T2 (de)
HK (1)	HK1060136A1 (de)
WO (1)	WO2001081387A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100426452B1 (ko) *	2001-01-02	2004-04-13	김진우	인간 원암 유전자로 형질전환된 포유동물 및 이 유전자를이용한 유방암, 신장암, 난소암 또는 위암 진단용 키트
EP1390518B1 (de) *	2001-04-23	2004-10-06	Amaxa GmbH	Pufferlössung für die elektroporation und verfahren umfassend die verwendung derselben
KR100434591B1 (ko) *	2002-04-16	2004-06-04	김진우	인간 암 억제 유전자, 이에 의해 코딩되는 단백질, 이를포함하는 발현 벡터 및 이 벡터로 형질전환된 세포
KR100664589B1 (ko) *	2004-12-28	2007-01-04	김현기	인간 암 억제 유전자, 이에 의해 코딩되는 단백질, 및이를 포함하는 발현 벡터
WO2008060776A2 (en) *	2006-10-03	2008-05-22	University Of Medicine And Dentistry Of New Jersey	Atap peptides, nucleic acids encoding the same and associated methods of use
KR101815322B1 (ko) *	2010-01-12	2018-01-05	서울대학교산학협력단	항암 펩타이드 서열

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR960034413A (ko) *	1995-03-24	1996-10-22	권계홍	아폽토시스 조절 유전자
AU1873097A (en) *	1996-02-14	1997-09-02	New England Deaconess Hospital Corporation	Gene therapy of entothelial cells with anti-apoptotic proteins for transplantation and inflammatory conditions
WO1999061612A1 (en) *	1998-05-28	1999-12-02	Incyte Pharmaceuticals, Inc.	Tumor suppressor
CA2296792A1 (en) *	1999-02-26	2000-08-26	Genset S.A.	Expressed sequence tags and encoded human proteins

2000
- 2000-04-25 KR KR10-2000-0021897A patent/KR100426455B1/ko not_active IP Right Cessation
- 2000-12-04 EP EP00983508A patent/EP1282641B1/de not_active Expired - Lifetime
- 2000-12-04 AT AT00983508T patent/ATE325812T1/de not_active IP Right Cessation
- 2000-12-04 CA CA002405983A patent/CA2405983A1/en not_active Abandoned
- 2000-12-04 WO PCT/KR2000/001406 patent/WO2001081387A1/en active IP Right Grant
- 2000-12-04 DE DE60027928T patent/DE60027928T2/de not_active Expired - Fee Related
- 2000-12-04 JP JP2001578474A patent/JP3749182B2/ja not_active Expired - Fee Related
- 2000-12-04 CN CN008193843A patent/CN1216909C/zh not_active Expired - Fee Related
- 2000-12-04 US US10/257,819 patent/US6977296B2/en not_active Expired - Fee Related
- 2000-12-04 AU AU2001220255A patent/AU2001220255A1/en not_active Abandoned
2004
- 2004-04-21 HK HK04102793A patent/HK1060136A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR20010097640A (ko)	2001-11-08
CA2405983A1 (en)	2001-11-01
EP1282641A1 (de)	2003-02-12
ATE325812T1 (de)	2006-06-15
EP1282641A4 (de)	2004-05-19
CN1216909C (zh)	2005-08-31
DE60027928T2 (de)	2007-01-04
EP1282641B1 (de)	2006-05-10
JP2003534783A (ja)	2003-11-25
US20040086974A1 (en)	2004-05-06
CN1451016A (zh)	2003-10-22
AU2001220255A1 (en)	2001-11-07
JP3749182B2 (ja)	2006-02-22
US6977296B2 (en)	2005-12-20
HK1060136A1 (en)	2004-07-30
WO2001081387A1 (en)	2001-11-01
KR100426455B1 (ko)	2004-04-13

Publication	Publication Date	Title
PT87562A (pt)	1989-05-31	Procede de expression de la proapolipoproteine a-i humaine
EP1548032A4 (de)	2006-03-01	Kdr-peptide und diese enthaltende impfstoffe
BG109433A (en)	2007-08-31	RET (RetL) Lead for Stimulating Nerve and Rat Growth
CA2461443A1 (en)	2003-04-17	Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
EP2114431A4 (de)	2011-03-16	Zusammensetzung mit arazym zur prävention und behandlung von krebs
BR9912279A (pt)	2002-01-02	Uso de uteroglobina humana recombinante no tratamento de condições inflamatórias e fibróticas
CA2449284A1 (en)	2003-01-30	Alpha-fetoprotein peptides and uses thereof
DE60027928D1 (de)	2006-06-14	MENSCHLICHES, GEBäRMUTTERKREBS-SPEZIFISCHES SUPPRESSORPROTEIN, FüR DAS PROTEIN KODIERES POLYNUKLEOTID, MIT DEM POLYNUKLEOTID TRANSFORMIERTE ZELLE UND VERFAHREN ZUR UNTERDRüCKUNG DER PROLIFERATION VON KREBSZELLEN UNTER VERWENDUNG DES EXPRESSIONSVEKTORS
ATE356145T1 (de)	2007-03-15	Polypeptide zur regenerierung des nervensystems
AU5327198A (en)	1998-06-29	Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
AR025482A1 (es)	2002-11-27	Secuencia de adn que codifica una proteina capaz de ligarse a traf; vector que comprende dicha secuencia; celulas huespedes transformadas con dicho vector;proteinas iren codificadas por dicha secuencia; metodo para producir dicha proteina; anticuerpos especificos para dichas proteinas; metodo para m
MX9806628A (es)	1998-12-31	Gen de respuesta de diferenciacion terminal mieloide humana novedoso.

Legal Events

Date	Code	Title	Description
2007-05-31	8364	No opposition during term of opposition
2009-10-22	8339	Ceased/non-payment of the annual fee